Latest Press Releases View all Oct 23, 2026 Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026 Oct 20, 2026 Vertex Appoints Daniel Brennan to its Board of Directors Oct 09, 2026 Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference View all Featured Media Library Items View all Reshma Kewalramani, M.D. Chief Executive Officer and President Download Duncan McKechnie Executive Vice President and Chief Commercial Officer Download Vertex International Headquarters – Lobby Download View all
Oct 23, 2026 Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026
Oct 09, 2026 Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference